Cytotoxic activity test of citrus mistletoe (Dendrophthoe glabrescens) leaves on breast cancer lines: in silico study -
Article metrics
OJS usage and citation sourcesViews and downloads are recorded by OJS; statistics processing may be delayed. A dash means the source count is unavailable. Search Google Scholar
Article Sidebar
Aditya Naova Sofyan, Rizal Maarif Rukmana, Andi Suhendi (2026). Cytotoxic activity test of citrus mistletoe (Dendrophthoe glabrescens) leaves on breast cancer lines: in silico study. Journal of Pharmaceutical and Sciences, JPS Volume 9 Nomor 1 (2026). https://doi.org/10.36490/journal-jps.com.v9i1.1417
Main Article Content
Abstract
This study aims investigate the potential of phytochemical compounds from citrus mistletoe leaves (Dendrophthoe glabrescens) leaves as anticancer candidates using an in silico approach. Phytocemical constituents identified by LC-MS and screened using Lipinski’s Rule of Five. Followed by Absorption, Distribution, Metabolism, Excretion and Toxicity (ADMET) prediction using ProTox-3.0. The docking protocol was validated with root mean square deviation (RMSD) values of 1.80 Å for epidermal growth factor receptor (EGFR) (PDB ID: 1M17) and 0.69 Å for estrogen receptor-α (ER-α) (PDB ID: 1A52). Tenylidone exhibited the strongest binding affinity toward EGFR (-8.12 kcal/mol), followed by quercetin (−7.48 kcal/mol) and kaempferol (−7.43 kcal/mol). For estrogen receptor alpha, fisetin showed the strongest affinity among the tested D. glabrescens compounds (−8.21 kcal/mol), followed by nomelidine (−8.16 kcal/mol) and tenylidone (−7.95 kcal/mol). Kaempferol showed the most favorable predicted acute toxicity profile among the leading compounds, with an estimated LD50 of 3919 mg/kg and toxicity class 5. Overall, tenylidone and fisetin were prioritized for epidermal growth factor receptor and estrogen receptor alpha, respectively, while kaempferol showed a favorable predicted safety profile.
Article Details
Section
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
How to Cite
References
Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA A Cancer J Clinicians 2024;74:229–63. https://doi.org/10.3322/caac.21834.
Lisiak N, Dzikowska P, Wisniewska U, Kaczmarek M, Bednarczyk-Cwynar B, Zaprutko L, et al. Biological Activity of Oleanolic Acid Derivatives HIMOXOL and Br-HIMOLID in Breast Cancer Cells Is Mediated by ER and EGFR. IJMS 2023;24:5099. https://doi.org/10.3390/ijms24065099.
Permatasanti A, Hidayat W. Potential of Indonesian Herbal as an Anti-Cancer Therapy: A Systemic Review of in vitro Studies. CMAR 2023;Volume 15:837–50. https://doi.org/10.2147/CMAR.S414457.
Ahmad R, Alqathama A, Aldholmi M, Riaz M, Mukhtar MH, Aljishi F, et al. Biological Screening of Glycyrrhiza glabra L. from Different Origins for Antidiabetic and Anticancer Activity. Pharmaceuticals 2022;16:7. https://doi.org/10.3390/ph16010007.
Artanti N, Firmansyah T, Darmawan A. Bioactivities Evaluation of Indonesian Mistletoes (Dendrophthoe pentandra (L.) Miq.) Leaves Extracts. Journal of Applied Pharmaceutical Science n.d.;02:24–7.
Subandrate S, Diba MF, Salni S, Triwani T, Nita S. Cytotoxicity, Antiproliferative and Apoptotic Effect of n-Hexane Fraction of Lime Parasite (Dendrophtoe pentandra). Molekul 2019;14:1. https://doi.org/10.20884/1.jm.2019.14.1.442.
Udayani NNW, Wiguna PDS, Cahyaningsih E, Wardani IGAAK. Skrining Fitokimia dan Aktivitas Antioksidan Ekstrak Daun Benalu Jeruk (Dendrophthoe glabrescens (Blakely) Barlow) dengan Pelarut n-Heksan dan Etanol. JINTO 2023;9:150–7. https://doi.org/10.36733/medicamento.v9i2.7136.
Slamet S, Khanifah M. Uji Toksisitas Fraksi N-Heksan dan Etanol, Ekstrak Daun Dendrophthoe glabrescen (Benalu Jeruk) sebagai Skrining Awal Anti-Kanker dengan Metode Brine Shrimp Lethality Test (BSLT) 2020.
Akinnusi PA, Olubode SO, Adebesin AO, Nana TA, Shodehinde SA. Discovery of Promising Inhibitors of Epidermal Growth Factor Receptor (EGFR), Human Epidermal Growth Factor Receptor 2 (HER2), Estrogen Receptor (ER), and Phosphatidylinositol-3-kinase a (PI3Ka) for Personalized Breast Cancer Treatment. Cancer Inform 2022;21:11769351221127862. https://doi.org/10.1177/11769351221127862.
Tsuraya A, Anugrah A, Aini N, Najah S, Sainidah S, Dwiwibangga Y, et al. In Silico Analysis of the Effectiveness of α-glucosidase Inhibitors (AGIs) on Phaseolus vulgaris L. as Antidiabetic Agents. JSMARTech 2022;3:43–51. https://doi.org/10.21776/ub.jsmartech.2022.003.02.43.
Banerjee P, Kemmler E, Dunkel M, Preissner R. ProTox 3.0: a webserver for the prediction of toxicity of chemicals. Nucleic Acids Research 2024;52:W513–20. https://doi.org/10.1093/nar/gkae303.
Gonzatti MB, Júnior JEM, Rocha AJ, De Oliveira JS, Evangelista AJDJ, Fonseca FMP, et al. Mechanism of molecular interaction of sitagliptin with human DPP4 enzyme - New Insights. Advances in Medical Sciences 2023;68:402–8. https://doi.org/10.1016/j.advms.2023.10.002.
Ivanović Violeta, Rančić M, Arsić B, Pavlovic A. Lipinski’s rule of five, fampous extensions and famous exceptions. J Cheminform 2020;3:171–7. https://doi.org/10.1186/s13321-015-0067-5.
Caminero Gomes Soares A, Marques Sousa GH, Calil RL, Goulart Trossini GH. Absorption matters: A closer look at popular oral bioavailability rules for drug approvals. Molecular Informatics 2023;42:e202300115. https://doi.org/10.1002/minf.202300115.
Minetti CA, Remeta DP. Forces Driving a Magic Bullet to Its Target: Revisiting the Role of Thermodynamics in Drug Design, Development, and Optimization. Life 2022;12:1438. https://doi.org/10.3390/life12091438.
Arif R, Ahmad S, Mustafa G, Mahrosh HS, Ali M, Tahir Ul Qamar M, et al. Molecular Docking and Simulation Studies of Antidiabetic Agents Devised from Hypoglycemic Polypeptide‐P of Momordica charantia. BioMed Research International 2021;2021:5561129. https://doi.org/10.1155/2021/5561129.
Irsal RAP, Gholam GM, Dwicesaria MA, Mansyah TF, Chairunisa F. Exploring the potential of Scabiosa columbaria in Alzheimer’s disease treatment: An in silico approach. Journal of Taibah University Medical Sciences 2024;19:947–60. https://doi.org/10.1016/j.jtumed.2024.09.003.
Alkorta I, Elguero J, Frontera A. Not Only Hydrogen Bonds: Other Noncovalent Interactions. Crystals 2020;10:180. https://doi.org/10.3390/cryst10030180.
Sun Q. The Hydrophobic Effects: Our Current Understanding. Molecules 2022;27:7009. https://doi.org/10.3390/molecules27207009.
Mahalapbutr P, Leechaisit R, Thongnum A, Todsaporn D, Prachayasittikul V, Rungrotmongkol T, et al. Discovery of Anilino-1,4-naphthoquinones as Potent EGFR Tyrosine Kinase Inhibitors: Synthesis, Biological Evaluation, and Comprehensive Molecular Modeling. ACS Omega 2022;7:17881–93. https://doi.org/10.1021/acsomega.2c01188.
Attwood MM, Fabbro D, Sokolov AV, Knapp S, Schiöth HB. Trends in kinase drug discovery: targets, indications and inhibitor design. Nat Rev Drug Discov 2021;20:839–61. https://doi.org/10.1038/s41573-021-00252-y.
Scannell JW, Bosley J, Hickman JA, Dawson GR, Truebel H, Ferreira GS, et al. Predictive validity in drug discovery: what it is, why it matters and how to improve it. Nat Rev Drug Discov 2022;21:915–31. https://doi.org/10.1038/s41573-022-00552-x.
Xue Q, Liu X, Russell P, Li J, Pan W, Fu J, et al. Evaluation of the binding performance of flavonoids to estrogen receptor alpha by Autodock, Autodock Vina and Surflex-Dock. Ecotoxicology and Environmental Safety 2022;233:113323. https://doi.org/10.1016/j.ecoenv.2022.113323.
Bafna D, Ban F, Rennie PS, Singh K, Cherkasov A. Computer-Aided Ligand Discovery for Estrogen Receptor Alpha. IJMS 2020;21:4193. https://doi.org/10.3390/ijms21124193.
Kriegel M, Wiederanders HJ, Alkhashrom S, Eichler J, Muller YA. A PROSS-designed extensively mutated estrogen receptor α variant displays enhanced thermal stability while retaining native allosteric regulation and structure. Sci Rep 2021;11:10509. https://doi.org/10.1038/s41598-021-89785-1.
Vereinte Nationen, editor. Globally harmonized system of classification and labelling of chemicals (GHS). eleventh revised edition. Geneva: United Nations; 2025.